» Articles » PMID: 35310341

Tetrahedral Framework Nucleic Acids-based Delivery of MicroRNA-155 Inhibits Choroidal Neovascularization by Regulating the Polarization of Macrophages

Overview
Journal Bioact Mater
Date 2022 Mar 21
PMID 35310341
Authors
Affiliations
Soon will be listed here.
Abstract

Choroidal neovascularization (CNV) is a common pathological feature of various eye diseases and an important cause of visual impairment in middle-aged and elderly patients. In previous studies, tetrahedral framework nucleic acids (tFNAs) showed good carrier performance. In this experiment, we developed microRNA-155-equipped tFNAs (T-155) and explored its biological effects on CNV. Based on the results of in-vitro experiments, T-155 could regulate macrophages into the antiangiogenic M1 type. Then, we injected T-155 into the vitreous of laser-induced CNV model mice and found that T-155 significantly reduced the size and area of CNV, inhibited blood vessel leakage. In summary, we prove that T-155 could regulate the inflammatory process of CNV by polarizing macrophages, thereby improving the symptoms of CNV. Thus, T-155 might become a new DNA-based drug with great potential for treating CNV.

Citing Articles

Engineered mitochondria in diseases: mechanisms, strategies, and applications.

Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y Signal Transduct Target Ther. 2025; 10(1):71.

PMID: 40025039 PMC: 11873319. DOI: 10.1038/s41392-024-02081-y.


Current Understanding and Translational Prospects of Tetrahedral Framework Nucleic Acids.

Gu J, Liang J, Tian T, Lin Y JACS Au. 2025; 5(2):486-520.

PMID: 40017737 PMC: 11862954. DOI: 10.1021/jacsau.4c01170.


Paeoniflorin Attenuates Limb Ischemia by Promoting Angiogenesis Through ERα/ROCK-2 Pathway.

Li M, Wang Q, Zhu S, Sun W, Ren X, Xu Z Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006085 PMC: 11859641. DOI: 10.3390/ph18020272.


Supramolecular Engineering of Nanoceria for Management and Amelioration of Age-Related Macular Degeneration via the Two-Level Blocking of Oxidative Stress and Inflammation.

Xu M, Zhou Y, Xu Y, Shao A, Han H, Ye J Adv Sci (Weinh). 2025; 12(9):e2408436.

PMID: 39792775 PMC: 11884525. DOI: 10.1002/advs.202408436.


Tetrahedral framework nucleic acids inhibit Aβ-mediated ferroptosis and ameliorate cognitive and synaptic impairments in Alzheimer's disease.

Tan L, Xie J, Liao C, Li X, Zhang W, Cai C J Nanobiotechnology. 2024; 22(1):682.

PMID: 39506721 PMC: 11542373. DOI: 10.1186/s12951-024-02963-x.


References
1.
Zhu Y, Tan W, Demetriades A, Cai Y, Gao Y, Sui A . Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization. Immunology. 2015; 147(4):414-28. PMC: 4799882. DOI: 10.1111/imm.12571. View

2.
Mettu P, Allingham M, Cousins S . Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities. Prog Retin Eye Res. 2020; 82:100906. PMC: 10368393. DOI: 10.1016/j.preteyeres.2020.100906. View

3.
Zhang P, Wang H, Luo X, Liu H, Lu B, Li T . MicroRNA-155 Inhibits Polarization of Macrophages to M2-Type and Suppresses Choroidal Neovascularization. Inflammation. 2017; 41(1):143-153. DOI: 10.1007/s10753-017-0672-8. View

4.
Tsutsumi C, Sonoda K, Egashira K, Qiao H, Hisatomi T, Nakao S . The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol. 2003; 74(1):25-32. DOI: 10.1189/jlb.0902436. View

5.
Droho S, Thomson B, Makinde H, Cuda C, Perlman H, Lavine J . Ocular macrophage origin and heterogeneity during steady state and experimental choroidal neovascularization. J Neuroinflammation. 2020; 17(1):341. PMC: 7666512. DOI: 10.1186/s12974-020-02010-0. View